Previous research suggests that glucose-lowering drugs (GLDs), including GLP-1 receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors, may offer a neuroprotective effect against dementia, but this association has yet to be confirmed
Emerging evidence suggests that these drugs, due to their ability to access the circumventricular organs such as the area postrema, a brain region involved in nausea responses may trigger this adverse effect
Gut Motility Support : May promote smoother intestinal contractions, supporting more regular bowel movements and easing constipation or diarrhea associated with IBS
Fayed B, Abood A, El-Sayed HS, Hashem AM, Mehanna NSH
Semaglutide (found in Ozempic and Wegovy) mimics a natural hormone (glucagon-like peptide-1, or GLP-1) to control appetite and help you feel satisfied with less food
Zepbound is FDA-approved for obstructive sleep apnea (OSA) in adults with obesity